AIDS and Clinical Infectious Diseases.While those with HIV have been prioritized by several countries, there were questions around how the immunosuppression from HIV could affect vaccine response, according to Aidsmap.The vaccines studied in these research projects were created based on messenger RNA, which is the type of vaccine that injects messenger RNA into muscle cells.
Those cells in turn create the immune response to fight off COVID-19.In the two projects, both from Johns Hopkins University School of Medicine in Baltimore, one explored the evolution of antibody responses after each of the two doses that each vaccine requires.